Breaking News, Collaborations & Alliances

Orgenesis Collaborates with MangoGen Pharma for Advanced Gene Delivery Platform

CDMO receives grant award to fund initial co-development program from the Canada-Israel Industrial R&D Foundation

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Orgenesis Inc., a developer, manufacturer and service provider of advanced cell therapies, has formed a collaboration with MangoGen Pharma initially focused on the pre-clinical development of insulin producing cells (IPC) using MangoGen’s advanced gene delivery platform. Under this initial collaboration, the companies will work together to develop a complete solution for the delivery of IPC cells to murine animal models. The company also announced that it has been awarded a grant from the Canada...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters